Decision on emergency authorisation for SII, Bharat Biotech’s COVID-19 vaccines deferred
Both manufacturers have been asked for more data before a final decision can be reached
Lateral Thoughts: Mix and match research
We still need to find the best vaccination protocol
Govt neither denies nor accepts adverse event in Serum Institute COVID-19 vaccine trial
Health secretary claims all procedures followed but refuses to divulge details
COVID-19: How is expiration date of vaccines determined?
Expired vaccines are not particularly unsafe or dangerous, say experts
How Rwanda reached first global COVID-19 vaccination target
Rwanda defined a vaccination plan prior to getting the vaccines
Global COVID-19 cases set to triple with over 3 billion omicron infections in coming 2-3 months: IHME
Australia and New Zealand may experience their worst outbreaks of this pandemic
New Delta+ variant found in India can escape antibodies
Mutations in the Delta+ variant can render vaccines and treatments ineffective
COVID-19 Vaccine Watch: COVAX has 2 billion doses to supply to 190 countries
End of COVID-19 pandemic in sight with arrival of these vaccines, says WHO
Protection against COVID-19 infection, severe disease falls quickly after AstraZeneca 2nd dose: Lancet
Begins to wane after 18-19 weeks; study stresses on need for booster dose
COVID-19 vaccine update: People above 45 eligible for jabs from April 1
Ministry of Home Affairs releases updated guidelines for COVID-19 control
Pfizer withdraws application for Emergency Use Authorisation in India
The company will resubmit application after getting more data